Sectors
Health, BioTech, Industrial
Headquarters
20 Acorn Park Drive, Cambridge, Massachusetts, 02140, USA
CEO
Devyn Smith
Arbor Biotechnologies's mutual fund disclosures indicate a three-month moving average fund price per share of $10.19 as of December 30, 2024, according to PM Insights' market data.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
Low
XXXXX
Business Partnerships

Targeted Impact

Who Will Benefit?

What Comes Next?
No items found.

Arbor Biotechnologies's mutual fund disclosures indicate a three-month moving average fund price per share of $10.19 as of December 30, 2024, according to PM Insights' market data.
No items found.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts